Re: Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid

Cheung VY, Vincent Y.T. Cheung
BJOG: An International Journal of Obstetrics & Gynaecology · 2017 · vol. 125(4) , pp. 508 · doi:10.1111/1471-0528.14977 · PMID:29148159 · W2768752365
Other OA: bronze CC0 ⤵ 2 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated changes in anti-Müllerian hormone levels after ultrasound-guided high-intensity focused ultrasound treatment for adenomyosis and uterine fibroids to assess its utility as a biomarker for ovarian reserve.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Leiomyoma Leiomyoma Anti-Mullerian Hormone Anti-Mullerian Hormone Biomarkers Biomarkers Female Female Humans Humans Ovarian Reserve Ovarian Reserve Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (2)

References (4)

Cited by (2)

Source provenance

europepmc
last seen: 2026-10-19T06:17:24.038039+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:20:50.926721+00:00
License: CC0 · commercial use OK